316 related articles for article (PubMed ID: 3931724)
21. Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia.
Kurec AS; Belair P; Stefanu C; Barrett DM; Dubowy RL; Davey FR
Cancer; 1991 Jun; 67(12):3081-6. PubMed ID: 2044051
[TBL] [Abstract][Full Text] [Related]
22. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
23. Immunologic classification of leukemia and lymphoma.
Foon KA; Todd RF
Blood; 1986 Jul; 68(1):1-31. PubMed ID: 2941082
[TBL] [Abstract][Full Text] [Related]
24. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta.
Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N
Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945
[TBL] [Abstract][Full Text] [Related]
25. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
Zipf TF; Fox RI; Dilley J; Levy R
Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
[TBL] [Abstract][Full Text] [Related]
26. Terminal deoxynucleotidyl transferase (TdT) in acute nonlymphocytic leukemia. A clinical, morphologic, cytochemical, immunologic, and ultrastructural study.
McCurley TL; Greer JP; Glick AD
Am J Clin Pathol; 1988 Oct; 90(4):421-30. PubMed ID: 2459954
[TBL] [Abstract][Full Text] [Related]
27. Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: different biologic features between T-cell antigen positive and B-cell antigen positive AML.
Tien HF; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH
Leukemia; 1993 May; 7(5):688-95. PubMed ID: 8483320
[TBL] [Abstract][Full Text] [Related]
28. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
[TBL] [Abstract][Full Text] [Related]
29. Antigen shared by human hemopoietic precursor cells and T and B lineage cells.
Fisher AG; Kumararatne DS; Khan M; Ismail S; Harper AM; Brown G
Hybridoma; 1983; 2(4):413-22. PubMed ID: 6332060
[TBL] [Abstract][Full Text] [Related]
30. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia.
Sobol RE; Mick R; Royston I; Davey FR; Ellison RR; Newman R; Cuttner J; Griffin JD; Collins H; Nelson DA
N Engl J Med; 1987 Apr; 316(18):1111-7. PubMed ID: 3494942
[TBL] [Abstract][Full Text] [Related]
31. Analysis of peroxidase-negative acute unclassifiable leukemias by monoclonal antibodies. 1. Acute myelogenous leukemia and acute myelomonocytic leukemia.
Imamura N; Tanaka R; Kajihara H; Kuramoto A
Eur J Haematol; 1988 Nov; 41(5):420-8. PubMed ID: 3061835
[TBL] [Abstract][Full Text] [Related]
32. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
33. Cellular and molecular studies on infant null acute lymphoblastic leukemia.
Katz F; Malcolm S; Gibbons B; Tilly R; Lam G; Robertson ME; Czepulkowski B; Chessells J
Blood; 1988 May; 71(5):1438-47. PubMed ID: 2965929
[TBL] [Abstract][Full Text] [Related]
34. Contribution of immunological markers to the diagnosis and prognosis of human leukemia.
von Fliedner V
Eur J Cancer Clin Oncol; 1985 Mar; 21(3):347-53. PubMed ID: 3159579
[TBL] [Abstract][Full Text] [Related]
35. Childhood leukemia with simultaneously expressed myeloid and lymphoid markers suggesting stem cell origin.
Terrin BN; Studer EJ; Wood N; Mohanakumar T; Russell EC
Am J Hematol; 1985 Oct; 20(2):175-81. PubMed ID: 2412438
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87.
Creutzig U; Harbott J; Sperling C; Ritter J; Zimmermann M; Löffler H; Riehm H; Schellong G; Ludwig WD
Blood; 1995 Oct; 86(8):3097-108. PubMed ID: 7579404
[TBL] [Abstract][Full Text] [Related]
37. Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis.
Ludwig WD; Bartram CR; Ritter J; Raghavachar A; Hiddemann W; Heil G; Harbott J; Seibt-Jung H; Teichmann JV; Riehm H
Blood; 1988 Jun; 71(6):1518-28. PubMed ID: 2967095
[TBL] [Abstract][Full Text] [Related]
38. Expression of myeloid differentiation antigens in acute nonlymphocytic leukemia: increased concentration of CD33 antigen predicts poor outcome--a report from the Childrens Cancer Study Group.
Dinndorf PA; Buckley JD; Nesbit ME; Lampkin BC; Piomelli S; Feig SA; Kersey JH; Hammond GD; Bernstein ID
Med Pediatr Oncol; 1992; 20(3):192-200. PubMed ID: 1574028
[TBL] [Abstract][Full Text] [Related]
39. Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristics.
Stong RC; Korsmeyer SJ; Parkin JL; Arthur DC; Kersey JH
Blood; 1985 Jan; 65(1):21-31. PubMed ID: 3917311
[TBL] [Abstract][Full Text] [Related]
40. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
